915 abstracts found.



Results filter

PTEN regulates centrosome orientation (CO) by lipid-phosphatase -dependent and -independent pathways

Year:

Session type:

Ishaan Jagan, Ravi kiran Deevi, Victoria Bingham, Charles Campbell

Centre for Cancer Research & Cell Biology, Queens University Belfast, UK


The use of Nutlin-3 as a radiosensitiser in laryngeal carcinoma cells harbouring wild-type p53

Year:

Session type:

Arvind Arya, Ashraf El-Fert, Timothy Devlin, Carlos Rubbi, Bryony Lloyd, John Fenwick, Terry Jones, Mark Boyd

University of Liverpool, Liverpool, Merseyside, UK


Life insurance rates among participants in the British Childhood Cancer Survivor Study

Year:

Session type:

Fabienne McClanahan, Clare Frobisher, David Winter, Emma Lancashire, Raoul Reulen, Mike Hawkins

Centre for Childhood Cancer Survivor Studies, University of Birmingham, UK


Systematic analysis of genetic alterations in prostate cancer

Year:

Session type:

Xueying Mao, Greg Shaw, Sharon James, Sakunthala Kudahetti, David Prowse, Tim Oliver, Bryan Young, Yong-Jie Lu

Queen Mary, University of London, London, UK


VEGF autocrine signalling maybe involved in proliferation of tumour initiating cells

Year:

Session type:

Emma Kenney-Herbert, Siolian Ball, Colin Watts

Brain Repair Centre, Cambridge, UK


The identification of transcriptional targets of TBX2 and their role in breast cancer proliferation

Year:

Session type:

Keara Redmond, Hannah Farmer, Zenobia D'Costa, Niamh Buckley, Caoimhe Nic An tSaoir, Dorota Tkocz, Paul Mullan

Queen's University, Belfast, UK


Activity of rapamycin against fresh human tumour and normal cells ex vivo

Year:

Session type:

Andrew G Bosanquet1, Justin Durant1, Sheila M Scadding1, Claudius E Rudin 2

1Bath Cancer Research, Bath, UK, 2Royal Devon and Exeter Hospital, Exeter, UK


Mortality from heart disease after radiotherapy for breast cancer

Year:

Session type:

Sarah Darby, on behalf of Collaborative Group on Observational Studies in Breast Cancer Survivors

Clinical Trial Service Unit, University of Oxford, UK


GMP production of therapeutic T-cells for a Cancer Research UK phase I clinical trial of autologous tumour antigen-specific T-cells for patients with advanced CEA positive tumours

Year:

Session type:

Ryan Guest1, Natalia Kirillova1, Joely Irlam-Jones1, Lidan Christie1, Eric Austin1, Keith Smith3, Robert Hawkins2

1NHS Blood and Transplant, Manchester, UK, 2University of Manchester, Manchester, UK, 3NHS Blood and Transplant, Cambridge, UK


Are post-menopausal women with early breast cancer in the UK receiving optimal treatment in line with NICE guidelines for the use of aromatase inhibitors?

Year:

Session type:

John Wagstaff1, Mark Verrill2, Mary McCormack3, Anthony Skene4

1South West Wales Cancer Institute, Swansea, UK, 2Northern Institute for Cancer Research, Newcastle General Hospital, Newcastle, UK, 3University College Hospital, London, UK, 4Nuffield Hospital, Bournemouth, UK


Page 25 of 92« First...25...50...Last »